Compare AAP & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAP | INSP |
|---|---|---|
| Founded | 1929 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | AAP | INSP |
|---|---|---|
| Price | $46.23 | $130.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 16 |
| Target Price | $52.18 | ★ $132.27 |
| AVG Volume (30 Days) | 1.4M | ★ 1.8M |
| Earning Date | 10-30-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | N/A | ★ 1.48 |
| Revenue | ★ $8,624,327,000.00 | $882,622,000.00 |
| Revenue This Year | N/A | $14.97 |
| Revenue Next Year | $1.08 | $11.81 |
| P/E Ratio | ★ N/A | $88.53 |
| Revenue Growth | N/A | ★ 16.81 |
| 52 Week Low | $28.89 | $70.77 |
| 52 Week High | $70.00 | $216.01 |
| Indicator | AAP | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 63.19 |
| Support Level | $45.45 | $132.39 |
| Resistance Level | $54.73 | $147.03 |
| Average True Range (ATR) | 2.31 | 8.60 |
| MACD | -0.41 | 0.20 |
| Stochastic Oscillator | 8.99 | 62.23 |
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.